TARSONS2024-10-012024-12-31 TARSONS2024-10-012024-12-31 TARSONS2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member TARSONS2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member TARSONS2024-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543399 TARSONS NOTLISTED Tarsons Products Limited Equity 2024-04-01 2025-03-31 2025-02-14 2025-01-31 INR Millions Third quarter 12:30:00 13:30:00 2025-02-14 2025-02-14 Not applicable Single segment Manufacturing & Selling of Plastic Laboratory Products and Instruments 2024-10-01 2024-12-31 Unaudited Standalone 761620000.00 21220000.00 782840000.00 195850000.00 22370000.00 880000.00 111130000.00 41270000.00 156110000.00 152240000.00 679850000.00 102990000.00 0.00 102990000.00 22760000.00 4100000.00 26860000.00 0.00 76130000.00 0.00 0.00 0.00 0.00 76130000.00 -190000.00 75940000.00 0.00 0.00 106410000.00 2 1.43 1.43 0.00 0.00 1.43 1.43 1.The above Statement of Standalone Unaudited Financial Results for the quarter and nine months ended December 31, 2024 ( Standalone Financial Results ) of Tarsons Products Limited (the Company) has been reviewed by the Audit Committee and then approved by the Board of Directors of the Company in their respective meetings held on February 14, 2025. 2. The aforesaid Standalone Financial Results has been prepared in accordance with the Indian Accounting Standards ( Ind AS ) prescribed under Section 133 of the Companies Act, 2013, as amended (the Act”) read with relevant rules thereunder and in terms of Regulations 33 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended ('Listing Regulations’). 3 The Company is primarily engaged in the business of manufacturing and selling of plastic laboratory products and certain scientic instruments, which represents a single business. The Board of Directors ( Chief Operating Decision Maker or CODM') reviews the financial results when making decisions about allocating resources and assessing performance of the Company as a whole and hence, the Company has concluded that the Company constitutes a single segment as per Ind AS 108 ‘Operating Segments'. 4 During the import of machinery, certain components were damaged during transit to India. The Company has estimated the amount of loss and has filed insurance claim which is under process. The Company has recorded a tolal provision of INR Nil and INR 93.44 million during the quarter and nine months ended December 31, 2024 respectively in relation to damage of such components. The Company will continue pursuing the insurance claim. Single segment 2024-04-01 2024-12-31 Unaudited Standalone 2211330000.00 176340000.00 2387670000.00 581530000.00 78090000.00 -30690000.00 327010000.00 130090000.00 365310000.00 571040000.00 2022380000.00 365290000.00 0.00 365290000.00 80730000.00 14540000.00 95270000.00 0.00 270020000.00 0.00 0.00 0.00 0.00 270020000.00 -570000.00 269450000.00 0.00 0.00 106410000.00 2 5.07 5.07 0.00 0.00 5.07 5.07 Other Expenses 152240000.00 Other Expenses 571040000.00 -250000.00 -760000.00 -60000.00 -190000.00 0.00 0.00